ANDREW FALAHEE: Open Payments
NPI 1720684418 · ANAHEIM, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$301 in 14 payments from 8 companies in 2025. Trend: 2023 $71 · 2024 $54 · 2025 $301
Food & beverage: $301
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $146 |
| PFIZER INC. | 2 | $41 |
| Novo Nordisk Inc | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| Amgen Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $15 |
Products named: QULIPTA, ELIQUIS, Wegovy, JYNARQUE, BEXSERO, GARDASIL 9, UBRELVY, EVENITY.
Industry payments across CA — which companies pay providers there.
